PPT-Lab Biosafety Focus Forum

Export Controls and Trade Sanctions Eileen Nielsen Director of Research Administration Education Office of Research Administration Harvard TH Chan School of Public Health US Export Controls. PETER PALESE. MOUNT SINAI SCHOOL OF MEDICINE, New York. BIOSECURITY, ISTANBUL, JULY 11, 2011. . Biosafety in Microbiological and Biomedical Laboratories. 5th Edition. U.S. Department of Health and Human Services. ONLY. NATIONAL CENTRE FOR CASE STUDY TEACHING IN SCIENCE. by. . NICOLE MARIE ANTHONY. . Biological Sciences Teacher. Toronto District School Board. 1. Group Brainstorming. Based on the information presented in the case so far, address the following questions in your groups:. YES NO ABO (or designee) reviews the Biosafety Summary and any additional materials necessary to assess the likelihood that the proposed activity will harm humans, animals, or the environment, according to internationally accepted biosafety risk assessment standards. •. . Biosafety overview. • Background. • Principles. • Containment. • Risk Assessment. • . Blood borne . Pathogens. What is Biosafety?. The . principles, practices, procedures, . and . containment . F Factor (Middle and High School Only, Advisor Led). Introduction and Rules. Back in the Day (In the Future Elementary). Similarity Activities (Time: Choose 1 or 2). Forum Bingo. Common Interests/Values. 30 Section IV—Laboratory Biosafety Level Criteria infectious microorganisms and laboratory animals are summarized in Table 2 of this section and discussed in Section 2. The levels are designated : RESEARCH ACTIVITIES I NVOLVING COVID - 19 SPECIMENS & SARS - CoV - 2 MATERIALS Activities / Materials Examples IBC A ction N eeded Key Biosafety E lements BSL - 3 Lab research a ctivities in Face Protective eyewear shall be worn for conduct of procedures in which splashes of microorganisms or other hazardous materials are possible. Hands Gloves must be worn when working with BSL1 materia Xia H, Huang Y, Ma H, Liu B, Xie W, Song D, et al. Biosafety Level 4 Laboratory User Training Program, China. Emerg Infect Dis. 2019;25(5). https://doi.org/10.3201/eid2505.180220. . in the lab. Dr. . Muthana. A. Al-. Shemeri. Muthanad@yahoo.com. CBRN Risks. Bio-threats in the 21st century. Governmental biological weapons programs. Non-state actors: bioterrorism. Naturally-occurring, emerging and . Your safety starts with you completing. :. Health . assessment at Corporate Health and Safety Services (CHSS). N95 respirator fit-testing at CHSS. Fire safety and security (online through the Learning Centre). by. Iruobe. Lauretta. outline. Introduction. Objectives. Biological Risks and Laboratory acquired infections. Routes of infections. Breaking the chains of infections. Elements concerned by biological risks and personnel exposed. biorisk. . policy and implementation: . perspectives . from the African continent. Dr. Louise Bezuidenhout. University of the Witwatersrand, South Africa. Outline. Research in Africa. Biosafety and biosecurity regulation and oversight. in accordance with . the Cartagena Protocol on Biosafety. Ministry of . Mahaweli Development and Environment. GLOBAL. ENVIRONMENT. FACILITY. Project . Components. Inception . Workshop . .